Todd Cozzens is the co-founder and Managing Partner of Leerink Transformation Partners (LTP) with over 25 years of experience in the healthcare information technology and services industry. Todd has led LTP’s investments in Health Catalyst, Outcome Health, Kyruus and PatientPing.
Prior to forming LTP in 2016, he co-led healthcare investing at Sequoia Capital where he invested in and helped build defining healthcare companies like Health Catalyst, MedExpress (sold to UnitedHealth Group for $1.5B, a sale in which Todd was instrumental), Natera (IPO in 2015 – NASDAQ: NTRA) and ZirMed (sold recently to Bain Capital for $750 M after Todd’s introduction) from early growth stages onward.
Prior to his time at Sequoia Capital, Todd led several business areas within Optum, a subsidiary of UnitedHealth Group, including strategy and M&A. Todd served as CEO of Optum’s Accountable Care Solutions business and helped with the formation and launch of Optum in 2011.
Todd himself provided the seed capital for and was the Co-founder and CEO of Picis, Inc., the market leader in electronic medical records for the high acuity areas of the hospital (operating rooms, intensive care units, and emergency departments); in 2010, Picis was acquired by UnitedHealth Group.
Before founding Picis, Todd started his operating career in healthcare by helping bootstrap and build Marquette Medical Systems and guiding it to leadership in cardiology diagnostics, patient monitoring and healthcare software solutions. He co-led the company’s IPO with the founder, and it was later acquired by GE for over $800 million.
Todd is a board member of current portfolio partner companies Health Catalyst, PatientPing, Outcome Health, and Kyruus (observer). He is also a board member of Natera (NASDAQ: NTRA), ZirMed, StemCentrx, and SCIO Health Analytics. He is a former board member of PerfectServe, MedExpress, and AirStrip.
Todd received a BA from Marquette University and completed Harvard Business School’s Program for Management Development (PMD). He sits on the executive committee of the InnerCity Scholarship Fund of Boston, as well as the Board of Overseers of Newton Wellesley Hospital. He is a member of the World Economic Forum’s Technology Council.